RecruitingNCT05619068

The Evolution and Prognosis of Moyamoya Disease

Imaging Investigation on the Evolution and Prognosis of Moyamoya Disease


Sponsor

Chinese PLA General Hospital

Enrollment

300 participants

Start Date

Sep 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

To investigate the evolution of imaging appearances and cognitive function of Moyamoya disease (MMD) and to establish a prognosis evaluation system based on imaging biomarkers in MMD. The study may be helpful to optimize and improve the diagnosis and pretreatment assessment of MMD, and provide an important theoretical supplement to the existing guidelines for the management of MMD.


Eligibility

Min Age: 10 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study follows patients with Moyamoya Disease — a rare brain blood vessel condition where the major arteries at the base of the brain become progressively narrowed or blocked, leading to strokes or other brain problems. Tiny new blood vessels form to compensate, creating a hazy appearance on scans (resembling a puff of smoke — hence "moyamoya" in Japanese). The study tracks how the disease evolves and affects thinking, memory, and quality of life over time. You may be eligible if: - You are between 10 and 60 years old - You have been diagnosed with Moyamoya Disease confirmed by angiography or MRI - You completed at least a primary school education (6 or more years of schooling) - You have signed informed consent You may NOT be eligible if: - You have had a massive brain infarction, multiple deep brain bleeds, or severely enlarged ventricles - You have vascular disease caused by an immune system disorder - You are unable to complete cognitive function tests - You have other neuropsychiatric conditions affecting cognition (e.g., Alzheimer's, Parkinson's, depression, anxiety disorder) - You have metal implants, a pacemaker, or other MRI contraindications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Chinese PLA General Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05619068


Related Trials